Literature DB >> 22210637

Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.

Catherine A Blish1, Ozge C Dogan, Walter Jaoko, R Scott McClelland, Kishorchandra Mandaliya, Katherine S Odem-Davis, Barbra A Richardsonb, Julie Overbaugh.   

Abstract

A case-control study was performed to determine the effects of HIV-1-specific cellular immune responses on the odds of acquiring a second HIV-1 infection (superinfection). Changes in the frequency of cytokine-producing or cytolytic CD8+ or CD4+ T cells were not associated with significant alterations in the odds of superinfection, suggesting that HIV-1 specific cellular immune responses at the level induced by chronic infection do not appear to significantly contribute to protection from HIV-1 superinfection.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22210637      PMCID： PMC3511787          DOI： 10.1097/QAD.0b013e3283509a0b

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  21 in total

1.  HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.

Authors:  Marcus Altfeld; Todd M Allen; Xu G Yu; Mary N Johnston; Deepak Agrawal; Bette T Korber; David C Montefiori; David H O'Connor; Ben T Davis; Paul K Lee; Erica L Maier; Jason Harlow; Philip J R Goulder; Christian Brander; Eric S Rosenberg; Bruce D Walker
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

Review 2.  HIV vaccines 1983-2003.

Authors:  Andrew J McMichael; Tomas Hanke
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

3.  A patient with HIV-1 superinfection.

Authors:  Stephanie Jost; Marie-Charlotte Bernard; Laurent Kaiser; Sabine Yerly; Bernard Hirschel; Assia Samri; Brigitte Autran; Li-Ean Goh; Luc Perrin
Journal:  N Engl J Med       Date:  2002-09-05       Impact factor: 91.245

4.  Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.

Authors:  Otto O Yang; Eric S Daar; Beth D Jamieson; Arumugam Balamurugan; Davey M Smith; Jacqueline A Pitt; Christos J Petropoulos; Douglas D Richman; Susan J Little; Andrew J Leigh Brown
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype.

Authors:  Bhavna Chohan; Ludo Lavreys; Stephanie M J Rainwater; Julie Overbaugh
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users.

Authors:  Artur Ramos; Dale J Hu; Lily Nguyen; Kim-Oanh Phan; Suphak Vanichseni; Nattawan Promadej; Kachit Choopanya; Margaret Callahan; Nancy L Young; Janet McNicholl; Timothy D Mastro; Thomas M Folks; Shambavi Subbarao
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.

Authors:  Agatha Masemola; Tumelo Mashishi; Greg Khoury; Phineas Mohube; Pauline Mokgotho; Efthyia Vardas; Mark Colvin; Lynn Zijenah; David Katzenstein; Rosemary Musonda; Susan Allen; Newton Kumwenda; Taha Taha; Glenda Gray; James McIntyre; Salim Abdool Karim; Haynes W Sheppard; Clive M Gray
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

9.  Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

Authors:  Y Rivière; M B McChesney; F Porrot; F Tanneau-Salvadori; P Sansonetti; O Lopez; G Pialoux; V Feuillie; M Mollereau; S Chamaret
Journal:  AIDS Res Hum Retroviruses       Date:  1995-08       Impact factor: 2.205

10.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.

Authors:  Photini Kiepiela; Kholiswa Ngumbela; Christina Thobakgale; Dhanwanthie Ramduth; Isobella Honeyborne; Eshia Moodley; Shabashini Reddy; Chantal de Pierres; Zenele Mncube; Nompumelelo Mkhwanazi; Karen Bishop; Mary van der Stok; Kriebashnie Nair; Nasreen Khan; Hayley Crawford; Rebecca Payne; Alasdair Leslie; Julia Prado; Andrew Prendergast; John Frater; Noel McCarthy; Christian Brander; Gerald H Learn; David Nickle; Christine Rousseau; Hoosen Coovadia; James I Mullins; David Heckerman; Bruce D Walker; Philip Goulder
Journal:  Nat Med       Date:  2006-12-17       Impact factor: 53.440
View more
  10 in total

Review 1.  Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.

Authors:  Yang Gao; Wen Tian; Xiaoxu Han; Feng Gao
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

2.  The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda.

Authors:  Andrew D Redd; Caroline E Mullis; David Serwadda; Xiangrong Kong; Craig Martens; Stacy M Ricklefs; Aaron A R Tobian; Changchang Xiao; Mary K Grabowski; Fred Nalugoda; Godfrey Kigozi; Oliver Laeyendecker; Joseph Kagaayi; Nelson Sewankambo; Ronald H Gray; Stephen F Porcella; Maria J Wawer; Thomas C Quinn
Journal:  J Infect Dis       Date:  2012-06-05       Impact factor: 5.226

3.  Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.

Authors:  Donald N Forthal; Gary Landucci; Bhavna Chohan; Barbra A Richardson; R Scott McClelland; Walter Jaoko; Catherine Blish; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

4.  HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Authors:  Marta E Bull; Jillian Legard; Kenneth Tapia; Bess Sorensen; Susan E Cohn; Rochelle Garcia; Sarah E Holte; Robert W Coombs; Jane E Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

Review 5.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

6.  Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine Odem-Davis; Barbra A Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

7.  HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women.

Authors:  Keshet Ronen; Connor O McCoy; Frederick A Matsen; David F Boyd; Sandra Emery; Katherine Odem-Davis; Walter Jaoko; Kishor Mandaliya; R Scott McClelland; Barbra A Richardson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823

8.  Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques.

Authors:  Jing Xue; Zhe Cong; Jing Xiong; Wei Wang; Hong Jiang; Ting Chen; Fangxin Wu; Kejian Liu; Aihua Su; Bin Ju; Zhiwei Chen; Marcelo A Couto; Qiang Wei; Chuan Qin
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

9.  Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women.

Authors:  Keshet Ronen; Adam S Dingens; Susan M Graham; Walter Jaoko; Kishor Mandaliya; R Scott McClelland; Julie Overbaugh
Journal:  EBioMedicine       Date:  2017-04-07       Impact factor: 8.143

10.  HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression.

Authors:  Chih-Hao Chang; Nicolaas C Kist; Tammy L Stuart Chester; Vattipally B Sreenu; Melissa Herman; Ma Luo; Daniel Lunn; John Bell; Francis A Plummer; T Blake Ball; Aris Katzourakis; Astrid K N Iversen
Journal:  Sci Rep       Date:  2015-06-17       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.